Role of gut–kidney axis in renal diseases and IgA nephropathy
Rôle de l'axe intestin/rein dans les maladies rénales et la néphropathie à IgA
Résumé
Purpose of review Growing evidence show the importance of gut/kidney axis in renal diseases. Advances in gut microbiome sequencing, associated metabolites, detection of gut permeability and inflammation provide new therapeutic strategies targeting gut for kidney diseases and particularly for Immunoglobulin A (IgA) nephropathy (IgAN). Recent findings The diversity and composition of gut flora have been recently deeply explored in kidney diseases. Modulation and depletion of microbiota in animal models allowed the understanding of molecular mechanisms involved in the crosstalk between gut, immune system and kidney. New clinical trials in order to positively modulate microbiota result in improvement of gastrointestinal disorders and inflammation in patients suffering with kidney diseases. Summary The investigation of gut alterations in kidney diseases open new therapeutic strategies. In IgAN, targeted treatments for intestinal inflammation and modifications of gut microbiota seem promising.
Domaines
Sciences du Vivant [q-bio]
Fichier principal
Monteiro et Berthelot curr opin gastroenterol 2021 version auteur.pdf (396.23 Ko)
Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)